AU2001278742A1 - Agents for ameliorating symptoms caused by joint diseases - Google Patents

Agents for ameliorating symptoms caused by joint diseases

Info

Publication number
AU2001278742A1
AU2001278742A1 AU2001278742A AU7874201A AU2001278742A1 AU 2001278742 A1 AU2001278742 A1 AU 2001278742A1 AU 2001278742 A AU2001278742 A AU 2001278742A AU 7874201 A AU7874201 A AU 7874201A AU 2001278742 A1 AU2001278742 A1 AU 2001278742A1
Authority
AU
Australia
Prior art keywords
agents
symptoms caused
joint diseases
ameliorating symptoms
ameliorating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001278742A
Inventor
Hideki Yoshikawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of AU2001278742A1 publication Critical patent/AU2001278742A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone (parathormone); Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
AU2001278742A 2000-08-16 2001-08-15 Agents for ameliorating symptoms caused by joint diseases Abandoned AU2001278742A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000247013 2000-08-16
JP2000-247013 2000-08-16
PCT/JP2001/007044 WO2002013865A1 (en) 2000-08-16 2001-08-15 Agents for ameliorating symptoms caused by joint diseases

Publications (1)

Publication Number Publication Date
AU2001278742A1 true AU2001278742A1 (en) 2002-02-25

Family

ID=18737191

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001278742A Abandoned AU2001278742A1 (en) 2000-08-16 2001-08-15 Agents for ameliorating symptoms caused by joint diseases

Country Status (5)

Country Link
US (1) US20040067231A1 (en)
EP (2) EP1849479A1 (en)
AU (1) AU2001278742A1 (en)
TW (1) TWI274586B (en)
WO (1) WO2002013865A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7318925B2 (en) * 2003-08-08 2008-01-15 Amgen Fremont, Inc. Methods of use for antibodies against parathyroid hormone
MXPA06001353A (en) 2003-08-08 2006-05-04 Abgenix Inc Antibodies directed to parathyroid hormone (pth) and uses thereof.
KR20230067696A (en) * 2016-06-23 2023-05-16 티톤 바이오테크, 인크. Cells expressing parathyroid hormone 1 receptor and uses thereof
US11103537B2 (en) 2016-06-23 2021-08-31 Tithon Biotech Inc. Cells expressing parathyroid hormone 1 receptor and uses thereof

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0759763B2 (en) 1986-03-24 1995-06-28 株式会社バイオマテリアル・ユニバース High-strength, high-modulus polyvinyl alcohol fiber and method for producing the same
US4771124A (en) * 1987-05-26 1988-09-13 Merck & Co., Inc. Parathyroid hormone antagonists with simplified synthetic methodology
US5001223A (en) * 1987-05-26 1991-03-19 Merck & Co., Inc. Parathyroid hormone antagonists with enhanced metabolic properties
US5217896A (en) * 1988-12-30 1993-06-08 Oncogene Science, Inc. Monoclonal antibodies recognizing parathyroid hormone-like protein
US6075181A (en) * 1990-01-12 2000-06-13 Abgenix, Inc. Human antibodies derived from immunized xenomice
JPH04228089A (en) * 1990-05-15 1992-08-18 Kanegafuchi Chem Ind Co Ltd Agent for treatment and prevention of hypercalcemia
US5849695A (en) * 1993-01-13 1998-12-15 The Regents Of The University Of California Parathyroid hormone analogues useful for treatment of osteoporosis and disorders of calcium meatabolism in mammals
JPH07316195A (en) * 1994-05-25 1995-12-05 Nippon Kayaku Co Ltd New pthrp-related peptide and use thereof
DE69535243T2 (en) 1994-07-13 2007-05-10 Chugai Seiyaku K.K. AGAINST HUMAN INTERLEUKIN-8 DIRECTED, RECONSTITUTED HUMAN ANTIBODY
CO4410206A1 (en) * 1994-07-28 1997-01-09 Sandoz Ag DERIVATIVES OF PTH or PTHrP, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM
US5626845A (en) * 1995-01-23 1997-05-06 Xenotech Incorporated Method to ameliorate osteolysis and metastasis
US5993817A (en) * 1995-01-23 1999-11-30 Xenotech Method to ameliorate osteolysis and metastasis
ATE363289T1 (en) * 1995-02-20 2007-06-15 Yukio Kato REMEDIES FOR ARTHROSIS DEFORMANS AND INFLAMMATORY JOINT DISEASES
US5660826A (en) * 1995-06-06 1997-08-26 The Regents Of The University Of California Therapeutic sepsis treatment using antagonists to PTHrP
US5700774A (en) * 1996-03-26 1997-12-23 Genetics Institute, Inc. Compositions comprising bone morphogenic proteins and truncated parathyroid hormone related peptide, and methods of inducing cartilage by administration of same
EP0962467A4 (en) * 1996-09-26 2002-10-30 Chugai Pharmaceutical Co Ltd Antibody against human parathormone related peptides
ES2285769T3 (en) * 1997-05-15 2007-11-16 Chugai Seiyaku Kabushiki Kaisha REMEDY FOR CAQUEXY.
JP2000080100A (en) * 1998-06-17 2000-03-21 Japan Tobacco Inc Human monoclonal antibody against parathyroid hormone-related protein
AU753131B2 (en) * 1998-06-26 2002-10-10 Chugai Seiyaku Kabushiki Kaisha Remedies for hypercalcemic crisis
TWI255718B (en) * 1999-07-02 2006-06-01 Chugai Pharmaceutical Co Ltd Ameliorative agent for low vasopressin concentration

Also Published As

Publication number Publication date
EP1312378A1 (en) 2003-05-21
EP1312378A4 (en) 2004-03-17
TWI274586B (en) 2007-03-01
US20040067231A1 (en) 2004-04-08
EP1849479A1 (en) 2007-10-31
WO2002013865A1 (en) 2002-02-21

Similar Documents

Publication Publication Date Title
AU2001249395A1 (en) Isolated instructions for isolated execution
HUP0200994A3 (en) Remedies for immunological diseases
AU2002243032A1 (en) Remdies for infant chronic arthritis-relating diseases
AU2002222118A1 (en) Pharmaceutical compositions for inhalation
AU3404901A (en) Constructive nanolithography
AU2002343739A1 (en) Improved therapy for topical diseases
AU2002214284A1 (en) Anti-helicobacterial agents
AU2001290685A1 (en) Methods for inhibiting inflammatory disease
AU2001267562A1 (en) Counter path ball joint
AU2002221906A1 (en) Method for diagnosing allergic diseases
AU2001291854A1 (en) Antibacterials mutilins
AU7074401A (en) Movement joint
AU2001248760A1 (en) Preventives/remedies for alzheimer's disease
AU2001278742A1 (en) Agents for ameliorating symptoms caused by joint diseases
AU2000254982A1 (en) Instrumented stent
AU2002315848A1 (en) Remedies for eosinophilic diseases
IL159478A0 (en) Remedies for eosinophilic diseases
AU2001232332A1 (en) Leptin-resistance ameliorating agents
AU2001236006A1 (en) Preventives/remedies for kidney diseases
AU2001273903A1 (en) Therapeutic agents
AU2002225347A1 (en) Elastic coupler
AU2003302320A1 (en) Seterocyclic quinones as pharmaceutical agents
AU2002304819A1 (en) Novel form of the phgpx protein as a diagnostic marker for male infertility
AU2001228863A1 (en) Remedies for ophthalmic diseases
AU2001271026A1 (en) Remedies for bone diseases